Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis

Prostate. 1997 Feb 15;30(3):183-7. doi: 10.1002/(sici)1097-0045(19970215)30:3<183::aid-pros6>3.0.co;2-n.

Abstract

Background: The most common site of metastases in prostate cancer is the skeleton and occurs in 70-80% of patients with prostate carcinoma. Calciotrophic peptides are important in the growth and development of normal bone matrix.

Methods: Three human prostate carcinoma cells lines, DU-145, PC-3, and LNCaP, were exposed to varying concentrations of parathyroid hormone (PTH) or calcitonin (CT). Cell proliferation and chemotaxis were assessed.

Results: Proliferation increased in LNCaP cells in a dose-dependent manner following treatment with PTH. Proliferation was not altered in PC-3 cells in response to PTH. Proliferation was decreased in DU-145 and PC-3 cells and increased in LNCaP cells after treatment with CT. Cell chemotaxis was increased in the presence of PTH in DU-145 and PC-3 cells compared to vehicle-treated controls.

Conclusions: The combined proliferation and chemotaxis data suggest that PTH has a dual role in prostate carcinoma resulting in an increase in the number and migration of selected prostate cancer cells. With CT, chemotaxis was unchanged in the DU-145 and PC-3 cells and significantly elevated in the LNCaP cell line. The calciotrophic hormones, PTH and CT, may play an integral role in the regulation of prostate cell growth and metastases.

MeSH terms

  • Calcitonin / pharmacology*
  • Carcinoma / drug therapy*
  • Carcinoma / physiopathology*
  • Cell Division / drug effects
  • Chemotaxis / drug effects*
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Parathyroid Hormone / pharmacology*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / physiopathology*
  • Tumor Cells, Cultured

Substances

  • Parathyroid Hormone
  • Calcitonin